Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
04:46a NCR : Digital Insight FIs to get Apple Touch ID for mobile banking apps
04:46a QUALCOMM : NXP, Qualcomm partner to accelerate NFC adoption
04:46a NCR : Authentic payment platform update touts integration, ease, security
04:46a GEMALTO : to secure BancNet's mobile services
04:46a INFOSYS : launches teenage-friendly mobile banking product
04:46a THESTREET : Study: improved security is key to success for mobile banking
04:46a CHINA CONSTRUCTION BANK : Transfast expands mobile, online funds transfer service into China
04:36a DUNKIN BRANDS : ' Brands' Government Affairs VP joins NRA as VP of Government Affairs & Policy
04:36a WENDYS : Former Pizza Hut chief of marketing joins Wendy's
04:36a RAVE RESTAURANT : reports positive Q3
Latest news
Advertisement
Hot News 
AMUR MINERALS : Kun-Manie Production Licence Awarded
CTRIP : Expedia Announces eLong Transaction
HAVELOCK EUROPA : Looks to the Future of Manufacturing in Fife
MIKRON : visiting a great British dish and a national institution ; DRAMA
SOITEC : Frances Soitec to sell solar activities to ConcenSolar
Most Read News
05/22 ETSY : BRIEF: Amazon reportedly set to debut Etsy rival dubbed Handmade
05/22 BLACKBERRY : cuts jobs worldwide as it consolidates businesses
05/22 SAJAN : Wrenching case of man dying in Austin hospital spurs feud over care
05/22 SIMON PROPERTY : Officials: Whistle-blower in Simon Property Group theft case found dead
05/22 TELEFONICA : Landing of submarine fiber-optic cable in Puerto Rico delayed
Most recommended articles
03:58a Bank of England confirms EU exit research after email misfire
03:43a South Korea seeks deeper cooperation with Japan on China-led AIIB
05/22 Yellen tone suggests choppiness for markets ahead
05/22DJSenate Passes Fast-Track Trade Legislation -- Update
05/22 A Fundamental Push for Key EURUSD, GBPUSD and USDJPY Levels?